{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,18]],"date-time":"2026-08-18T03:27:10Z","timestamp":1787023630140,"version":"build-2736575974"},"reference-count":59,"publisher":"Impact Journals, LLC","issue":"18","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Aging"],"published-print":{"date-parts":[[2023,9,30]]},"DOI":"10.18632\/aging.205043","type":"journal-article","created":{"date-parts":[[2023,9,19]],"date-time":"2023-09-19T13:36:58Z","timestamp":1695130618000},"page":"9695-9717","source":"Crossref","is-referenced-by-count":3,"title":["Characterization of tumor microenvironment and sensitive chemotherapy drugs based on cuproptosis-related signatures in renal cell carcinoma"],"prefix":"10.18632","volume":"15","author":[{"given":"Jiefu","family":"Tang","sequence":"first","affiliation":[{"name":"The First Affiliated Hospital of Hunan University of Medicine, School of Public Health and Laboratory Medicine, Hunan University of Medicine, Huaihua 418000, Hunan, P.R. China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fan","family":"Yao","sequence":"additional","affiliation":[{"name":"The First Affiliated Hospital of Hunan University of Medicine, School of Public Health and Laboratory Medicine, Hunan University of Medicine, Huaihua 418000, Hunan, P.R. China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhiyong","family":"Yao","sequence":"additional","affiliation":[{"name":"The First Affiliated Hospital of Hunan University of Medicine, School of Public Health and Laboratory Medicine, Hunan University of Medicine, Huaihua 418000, Hunan, P.R. China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiao-Liang","family":"Xing","sequence":"additional","affiliation":[{"name":"The First Affiliated Hospital of Hunan University of Medicine, School of Public Health and Laboratory Medicine, Hunan University of Medicine, Huaihua 418000, Hunan, P.R. China"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"7892","published-online":{"date-parts":[[2023,9,19]]},"reference":[{"key":"1","doi-asserted-by":"publisher","first-page":"922780","DOI":"10.3389\/fimmu.2022.922780","article-title":"Prognostic analysis of cuproptosis-related gene in triple-negative breast cancer.","volume":"1","author":"Li","year":"2022","journal-title":"Front Immunol"},{"key":"2","doi-asserted-by":"publisher","first-page":"378","DOI":"10.1038\/s41392-022-01229-y","article-title":"Copper homeostasis and cuproptosis in health and disease.","volume":"7","author":"Wang","year":"2022","journal-title":"Signal Transduct Target Ther"},{"key":"3","doi-asserted-by":"publisher","first-page":"1254","DOI":"10.1126\/science.abf0529","article-title":"Copper induces cell death by targeting lipoylated TCA cycle proteins.","volume":"37","author":"Kocak","year":"2022","journal-title":"Science"},{"key":"4","doi-asserted-by":"publisher","first-page":"3594","DOI":"10.3390\/cancers12123594","article-title":"The Multifaceted Roles of Copper in Cancer: A Trace Metal Element with Dysregulated Metabolism, but Also a Target or a Bullet for Therapy.","volume":"1","author":"Busser","year":"2020","journal-title":"Cancers (Basel)"},{"key":"5","doi-asserted-by":"publisher","first-page":"1900","DOI":"10.1002\/iub.2341","article-title":"Copper homeostasis: Emerging target for cancer treatment.","volume":"7","author":"Li","year":"2020","journal-title":"IUBMB Life"},{"key":"6","doi-asserted-by":"publisher","first-page":"711227","DOI":"10.3389\/fmolb.2021.711227","article-title":"Role of Copper on Mitochondrial Function and Metabolism.","volume":"8","author":"Elorza","year":"2021","journal-title":"Front Mol Biosci"},{"key":"7","doi-asserted-by":"publisher","first-page":"102","DOI":"10.1038\/s41568-021-00417-2","article-title":"Connecting copper and cancer: from transition metal signalling to metalloplasia.","volume":"2","author":"Mittal","year":"2022","journal-title":"Nat Rev Cancer"},{"key":"8","doi-asserted-by":"publisher","first-page":"209","DOI":"10.3322\/caac.21660","article-title":"Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries.","volume":"7","author":"Bray","year":"2021","journal-title":"CA Cancer J Clin"},{"key":"9","doi-asserted-by":"publisher","first-page":"519","DOI":"10.1016\/j.eururo.2014.10.002","article-title":"International variations and trends in renal cell carcinoma incidence and mortality.","volume":"6","author":"Bray","year":"2015","journal-title":"Eur Urol"},{"key":"10","doi-asserted-by":"publisher","first-page":"507","DOI":"10.1016\/j.urolonc.2017.05.006","article-title":"Heterogeneity in renal cell carcinoma.","volume":"3","author":"Badani","year":"2017","journal-title":"Urol Oncol"},{"key":"11","doi-asserted-by":"publisher","first-page":"484","DOI":"10.4329\/wjr.v8.i5.484","article-title":"Review of renal cell carcinoma and its common subtypes in radiology.","volume":"8","author":"Girgis","year":"2016","journal-title":"World J Radiol"},{"key":"12","doi-asserted-by":"publisher","first-page":"260","DOI":"10.1111\/bju.12950","article-title":"Renal cell cancer histological subtype distribution differs by race and sex.","volume":"11","author":"Clark","year":"2016","journal-title":"BJU Int"},{"key":"13","doi-asserted-by":"publisher","first-page":"6236","DOI":"10.1158\/1078-0432.CCR-15-1217","article-title":"DNA Methylation Signature Reveals Cell Ontogeny of Renal Cell Carcinomas.","volume":"2","author":"Khayat","year":"2016","journal-title":"Clin Cancer Res"},{"key":"14","doi-asserted-by":"publisher","first-page":"103287","DOI":"10.1016\/j.critrevonc.2021.103287","article-title":"Comprehensive review of chromophobe renal cell carcinoma.","volume":"16","author":"Dahmoush","year":"2021","journal-title":"Crit Rev Oncol Hematol"},{"key":"15","doi-asserted-by":"publisher","first-page":"17009","DOI":"10.1038\/nrdp.2017.9","article-title":"Renal cell carcinoma.","volume":"3","author":"Ficarra","year":"2017","journal-title":"Nat Rev Dis Primers"},{"key":"16","doi-asserted-by":"publisher","first-page":"2476","DOI":"10.1016\/j.celrep.2016.02.024","article-title":"Multilevel Genomics-Based Taxonomy of Renal Cell Carcinoma.","volume":"1","author":"Covington","year":"2016","journal-title":"Cell Rep"},{"key":"17","doi-asserted-by":"publisher","first-page":"1119","DOI":"10.1016\/S0140-6736(09)60229-4","article-title":"Renal cell carcinoma.","volume":"37","author":"Escudier","year":"2009","journal-title":"Lancet"},{"key":"18","doi-asserted-by":"publisher","first-page":"165","DOI":"10.21037\/atm.2018.04.44","article-title":"Survival outcomes for advanced kidney cancer patients in the era of targeted therapies.","volume":"6","author":"Lauer","year":"2018","journal-title":"Ann Transl Med"},{"key":"19","doi-asserted-by":"publisher","first-page":"38","DOI":"10.1016\/j.semcancer.2012.06.004","article-title":"Current and future systemic treatments for renal cell carcinoma.","volume":"2","author":"Larkin","year":"2013","journal-title":"Semin Cancer Biol"},{"key":"20","doi-asserted-by":"publisher","first-page":"eaaw5473","DOI":"10.1126\/science.aaw5473","article-title":"Metabolic reprogramming and cancer progression.","volume":"36","author":"DeBerardinis","year":"2020","journal-title":"Science"},{"key":"21","doi-asserted-by":"publisher","first-page":"1116","DOI":"10.1056\/NEJMoa1816714","article-title":"Pembrolizumab plus Axitinib versus Sunitinib for Advanced Renal-Cell Carcinoma.","volume":"38","author":"Bondarenko","year":"2019","journal-title":"N Engl J Med"},{"key":"22","doi-asserted-by":"publisher","first-page":"4129","DOI":"10.1158\/0008-5472.CAN-20-0471","article-title":"Intratumoral Copper Modulates PD-L1 Expression and Influences Tumor Immune Evasion.","volume":"8","author":"Mayoh","year":"2020","journal-title":"Cancer Res"},{"key":"23","doi-asserted-by":"publisher","first-page":"108","DOI":"10.1038\/s41523-021-00313-w","article-title":"Tetrathiomolybdate (TM)-associated copper depletion influences collagen remodeling and immune response in the pre-metastatic niche of breast cancer.","volume":"7","author":"Ward","year":"2021","journal-title":"NPJ Breast Cancer"},{"key":"24","doi-asserted-by":"publisher","first-page":"2014","DOI":"10.3390\/jcm12052014","article-title":"Identification of a Novel Cuproptosis-Related Gene Signature and Integrative Analyses in Thyroid Cancer.","volume":"1","author":"Zhang","year":"2023","journal-title":"J Clin Med"},{"key":"25","doi-asserted-by":"publisher","first-page":"940774","DOI":"10.3389\/fimmu.2022.940774","article-title":"A novel cuproptosis-related molecular pattern and its tumor microenvironment characterization in colorectal cancer.","volume":"1","author":"Xu","year":"2022","journal-title":"Front Immunol"},{"key":"26","doi-asserted-by":"publisher","first-page":"174","DOI":"10.1186\/s13045-022-01392-3","article-title":"Targeting cell death pathways for cancer therapy: recent developments in necroptosis, pyroptosis, ferroptosis, and cuproptosis research.","volume":"1","author":"Shi","year":"2022","journal-title":"J Hematol Oncol"},{"key":"27","doi-asserted-by":"publisher","first-page":"46","DOI":"10.1186\/s12943-023-01732-y","article-title":"Cuproptosis: mechanisms and links with cancers.","volume":"2","author":"He","year":"2023","journal-title":"Mol Cancer"},{"key":"28","doi-asserted-by":"publisher","first-page":"4661929","DOI":"10.1155\/2022\/4661929","article-title":"Construction of a Prognostic Model Based on Cuproptosis-Related lncRNA Signatures in Pancreatic Cancer.","volume":"202","author":"Zhou","year":"2022","journal-title":"Can J Gastroenterol Hepatol"},{"key":"29","doi-asserted-by":"publisher","first-page":"7929132","DOI":"10.1155\/2020\/7929132","article-title":"Identification of a Seven-lncRNA Immune Risk Signature and Construction of a Predictive Nomogram for Lung Adenocarcinoma.","volume":"202","author":"Zhang","year":"2020","journal-title":"Biomed Res Int"},{"key":"30","doi-asserted-by":"publisher","first-page":"331","DOI":"10.1186\/s12967-020-02497-4","article-title":"Identification and validation of stemness-related lncRNA prognostic signature for breast cancer.","volume":"1","author":"Jin","year":"2020","journal-title":"J Transl Med"},{"key":"31","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1159\/000522653","article-title":"Downregulation of lncRNA FOXD2-AS1 Confers Radiosensitivity to Gastric Cancer Cells via miR-1913\/SETD1A Axis.","volume":"16","author":"Zhang","year":"2022","journal-title":"Cytogenet Genome Res"},{"key":"32","doi-asserted-by":"publisher","first-page":"10633","DOI":"10.2147\/CMAR.S228628","article-title":"LncRNA FOXD2-AS1 Regulates miR-25-3p\/Sema4c Axis To Promote The Invasion And Migration Of Colorectal Cancer Cells.","volume":"1","author":"He","year":"2019","journal-title":"Cancer Manag Res"},{"key":"33","doi-asserted-by":"publisher","first-page":"10234","DOI":"10.26355\/eurrev_201912_19660","article-title":"LncRNA FOXD2-AS1 accelerates the progression of cervical cancer via downregulating CDX1.","volume":"2","author":"Chen","year":"2019","journal-title":"Eur Rev Med Pharmacol Sci"},{"key":"34","doi-asserted-by":"publisher","first-page":"307","DOI":"10.3892\/etm.2021.9738","article-title":"Long non-coding RNA FOXD2-AS1 promotes proliferation, migration and invasion of ovarian cancer cells via regulating the expression of miR-4492.","volume":"2","author":"Zhang","year":"2021","journal-title":"Exp Ther Med"},{"key":"35","doi-asserted-by":"publisher","first-page":"7723425","DOI":"10.1155\/2022\/7723425","article-title":"lncRNA FOXD2-AS1 Promotes the Retinoblastoma Cell Viability and Migration by Sponging miR-31.","volume":"202","author":"Yin","year":"2022","journal-title":"Biomed Res Int"},{"key":"36","doi-asserted-by":"publisher","first-page":"2209","DOI":"10.2217\/fon-2020-0410","article-title":"FOXD2-AS1 promotes migration and invasion of head and neck squamous cell carcinoma and predicts poor prognosis.","volume":"1","author":"Zhang","year":"2020","journal-title":"Future Oncol"},{"key":"37","doi-asserted-by":"publisher","first-page":"963689720964411","DOI":"10.1177\/0963689720964411","article-title":"FOXD2-AS1 Predicts Dismal Prognosis for Oral Squamous Cell Carcinoma and Regulates Cell Proliferation.","volume":"2","author":"Wu","year":"2020","journal-title":"Cell Transplant"},{"key":"38","doi-asserted-by":"publisher","first-page":"4673514","DOI":"10.1155\/2022\/4673514","article-title":"A Cuproptosis-Related lncRNAs Signature Could Accurately Predict Prognosis in Patients with Clear Cell Renal Cell Carcinoma.","volume":"202","author":"Ma","year":"2022","journal-title":"Anal Cell Pathol (Amst)"},{"key":"39","doi-asserted-by":"publisher","first-page":"18757","DOI":"10.1038\/s41598-022-16972-z","article-title":"LINC00839 promotes malignancy of liver cancer via binding FMNL2 under hypoxia.","volume":"1","author":"Li","year":"2022","journal-title":"Sci Rep"},{"key":"40","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1007\/s10517-022-05498-z","article-title":"LINC00839 Promotes the Progression of Gastric Cancer by Sponging miR-1236-3p.","volume":"17","author":"Cao","year":"2022","journal-title":"Bull Exp Biol Med"},{"key":"41","doi-asserted-by":"publisher","first-page":"e54128","DOI":"10.15252\/embr.202154128","article-title":"LINC00839 promotes colorectal cancer progression by recruiting RUVBL1\/Tip60 complexes to activate NRF1.","volume":"2","author":"Zhou","year":"2022","journal-title":"EMBO Rep"},{"key":"42","doi-asserted-by":"publisher","first-page":"2278","DOI":"10.1007\/s11064-022-03613-0","article-title":"LINC00839 Promotes Neuroblastoma Progression by Sponging miR-454-3p to Up-Regulate NEUROD1.","volume":"4","author":"Liu","year":"2022","journal-title":"Neurochem Res"},{"key":"43","doi-asserted-by":"publisher","first-page":"931383","DOI":"10.3389\/fonc.2022.931383","article-title":"Establishing a prognostic model of ferroptosis- and immune-related signatures in kidney cancer: A study based on TCGA and ICGC databases.","volume":"1","author":"Xing","year":"2022","journal-title":"Front Oncol"},{"key":"44","doi-asserted-by":"publisher","first-page":"2215","DOI":"10.1111\/jcmm.14886","article-title":"Expression signature of six-snoRNA serves as novel non-invasive biomarker for diagnosis and prognosis prediction of renal clear cell carcinoma.","volume":"2","author":"Chen","year":"2020","journal-title":"J Cell Mol Med"},{"key":"45","doi-asserted-by":"publisher","first-page":"3632576","DOI":"10.1155\/2021\/3632576","article-title":"Identification and Validation of PIK3CA as a Marker Associated with Prognosis and Immune Infiltration in Renal Clear Cell Carcinoma.","volume":"202","author":"Zhou","year":"2021","journal-title":"J Oncol"},{"key":"46","doi-asserted-by":"publisher","first-page":"1235","DOI":"10.21037\/atm-22-5204","article-title":"Clinical significance and immune landscape of cuproptosis-related lncRNAs in kidney renal clear cell carcinoma: a bioinformatical analysis.","volume":"1","author":"Zhang","year":"2022","journal-title":"Ann Transl Med"},{"key":"47","doi-asserted-by":"publisher","first-page":"2612","DOI":"10.1038\/ncomms3612","article-title":"Inferring tumour purity and stromal and immune cell admixture from expression data.","volume":"4","author":"Stemke-Hale","year":"2013","journal-title":"Nat Commun"},{"key":"48","doi-asserted-by":"publisher","first-page":"8971","DOI":"10.1038\/ncomms9971","article-title":"Systematic pan-cancer analysis of tumour purity.","volume":"6","author":"Butte","year":"2015","journal-title":"Nat Commun"},{"key":"49","doi-asserted-by":"publisher","first-page":"e0270669","DOI":"10.1371\/journal.pone.0270669","article-title":"Interferon-alpha2 treatment of patients with polycythemia vera and related neoplasms favorably impacts deregulation of oxidative stress genes and antioxidative defense mechanisms.","volume":"1","author":"Hasselbalch","year":"2022","journal-title":"PLoS One"},{"key":"50","doi-asserted-by":"publisher","first-page":"954440","DOI":"10.3389\/fimmu.2022.954440","article-title":"Cuproptosis status affects treatment options about immunotherapy and targeted therapy for patients with kidney renal clear cell carcinoma.","volume":"1","author":"Cao","year":"2022","journal-title":"Front Immunol"},{"key":"51","doi-asserted-by":"publisher","first-page":"971142","DOI":"10.3389\/fimmu.2022.971142","article-title":"The cuproptosis-associated 13 gene signature as a robust predictor for outcome and response to immune- and targeted-therapies in clear cell renal cell carcinoma.","volume":"1","author":"Xu","year":"2022","journal-title":"Front Immunol"},{"key":"52","doi-asserted-by":"publisher","first-page":"952129","DOI":"10.3389\/fonc.2022.952129","article-title":"Comprehensive analysis of the potential cuproptosis-related biomarker LIAS that regulates prognosis and immunotherapy of pan-cancers.","volume":"1","author":"Bai","year":"2022","journal-title":"Front Oncol"},{"key":"53","doi-asserted-by":"publisher","first-page":"106132","DOI":"10.1016\/j.jsbmb.2022.106132","article-title":"AZD4547 and calcitriol synergistically inhibited BT-474 cell proliferation while modified stemness and tumorsphere formation.","volume":"22","author":"D\u00edaz","year":"2022","journal-title":"J Steroid Biochem Mol Biol"},{"key":"54","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1007\/s13402-021-00645-6","article-title":"AZD4547 targets the FGFR\/Akt\/SOX2 axis to overcome paclitaxel resistance in head and neck cancer.","volume":"4","author":"Karatas","year":"2022","journal-title":"Cell Oncol (Dordr)"},{"key":"55","doi-asserted-by":"publisher","first-page":"757598","DOI":"10.3389\/fonc.2021.757598","article-title":"Anti-Tumor Activity of AZD4547 Against NTRK1 Fusion Positive Cancer Cells Through Inhibition of NTRKs.","volume":"1","author":"Sim","year":"2021","journal-title":"Front Oncol"},{"key":"56","doi-asserted-by":"publisher","first-page":"5340","DOI":"10.3390\/molecules26175340","article-title":"Influence of Vincristine, Clinically Used in Cancer Therapy and Immune Thrombocytopenia, on the Function of Human Platelets.","volume":"2","author":"Sheu","year":"2021","journal-title":"Molecules"},{"key":"57","doi-asserted-by":"publisher","first-page":"377","DOI":"10.1007\/s00204-022-03418-8","article-title":"Proactive therapeutic drug monitoring of vincristine in pediatric and adult cancer patients: current supporting evidence and future efforts.","volume":"9","author":"Chen","year":"2023","journal-title":"Arch Toxicol"},{"key":"58","doi-asserted-by":"publisher","first-page":"109978","DOI":"10.1016\/j.cbi.2022.109978","article-title":"BCL2 inhibitor ABT-199 and BCL2L1 inhibitor WEHI-539 coordinately promote NOXA-mediated degradation of MCL1 in human leukemia cells.","volume":"36","author":"Chang","year":"2022","journal-title":"Chem Biol Interact"},{"key":"59","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1186\/s13048-016-0234-y","article-title":"Antagonism of Bcl-XL is necessary for synergy between carboplatin and BH3 mimetics in ovarian cancer cells.","volume":"9","author":"Richardson","year":"2016","journal-title":"J Ovarian Res"}],"container-title":["Aging"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.aging-us.com\/lookup\/doi\/10.18632\/aging.205043","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,5]],"date-time":"2023-10-05T15:20:04Z","timestamp":1696519204000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.aging-us.com\/lookup\/doi\/10.18632\/aging.205043"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,9,19]]},"references-count":59,"journal-issue":{"issue":"18","published-print":{"date-parts":[[2023,9,30]]}},"alternative-id":["205043","37728407"],"URL":"https:\/\/doi.org\/10.18632\/aging.205043","relation":{},"ISSN":["1945-4589"],"issn-type":[{"value":"1945-4589","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,9,19]]}}}